Is there a role for telemedicine in adult allergy services? by Krishna, Mamidipudi T. et al.
1 
 
 
Is there a role for telemedicine in adult allergy 
services ? 
 
Mamidipudi T. Krishna+#, Rebecca C. Knibb# and Aarnoud P. Huissoon+ 
 
+Heart of England NHS Foundation Trust (HEFT), Birmingham, UK 
#Aston University, Birmingham, UK 
 
 
Short title: Telemedicine and adult allergy service 
 
 
 
 
 
Address for correspondence 
Dr. M. T. Krishna 
Department of Allergy and Immunology 
Birmingham Heartlands Hospital 
Bordesley Green East 
Birmingham B9 5SS 
Email: mtkrishna@yahoo.com 
Tel: +44 121 4241807 
Fax: +44 121 4243229  
2 
 
Abstract 
Telemedicine refers to the application of telecommunication and information technology (IT) 
in the delivery of health and clinical care at a distance or remotely and can be broadly 
considered in two modalities: store-and-forward  and real-time interactive services.   
Preliminary studies have shown promising results in radiology, dermatology, intensive care, 
diabetes, rheumatology and primary care. However, the evidence is limited and hampered by 
small sample sizes, paucity of randomised controlled studies and lack of data relating to cost-
effectiveness, health related quality of life and patient and clinician satisfaction.  This review 
appraises the evidence from studies that have employed telemedicine tools in other 
disciplines and makes suggestions for its potential applications in specific clinical scenarios 
in adult allergy services.  Possible examples include: triaging patients to determine the need 
for allergy tests; pre-assessment for specialised treatments such as allergen immunotherapy; 
follow up to assess treatment response and side effects; and education in self-management 
plan including training updates for self-injectable adrenaline and nasal spray use.  This 
approach might improve access for those with limited mobility or living far away from 
regional centres, as well as bringing convenience and cost savings for the patient and service 
provider.  These potential benefits need to be carefully weighed against evidence of service 
safety and quality.  Keys to success include delineation of appropriate clinical scenarios, 
patient selection, training, IT support and robust information governance framework.  Well-
designed prospective studies are needed to evaluate its role. 
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Introduction 
The use of telecommunications in medicine is nothing new; the first telephone exchange in 
Glasgow in 1879 was specifically installed for doctors. However, recent rapid advances in the 
information technology (IT) industry have had a remarkable global impact on the lives of the 
public and it is inevitable that this will influence health service delivery options and 
expectations amongst patients and health care professionals.  Importantly, IT has enabled 
health care professionals to store and transmit clinical data in order to expedite clinical 
decision-making within and between primary, secondary and tertiary care. 
Telemedicine is the use of telecommunication and IT in the delivery of health and clinical 
care at a distance or remotely.  This could be without the patient physically meeting the 
health care professional during the entire treatment pathway but is more commonly used in 
specific clinical scenarios or certain aspects of management following initial evaluation.   
The main objective of this review is to consider whether current models of telemedicine 
could be applied to clinical allergy services.    These models may help address the unmet 
need for these services, which is further compounded by recent re-structuring of specialist 
services and the associated financial squeeze within the United Kingdom (UK) National 
Health Service (NHS).   
Types of telemedicine 
Broadly speaking telemedicine can be offered using 2 modalities singly or in combination:  
1. Store-and-Forward:  This involves transmission of packets of data relating to 
investigations such as digital images in radiology/pathology, use of high resolution 
digital cameras in dermatology, digital otoscopes, digital stethoscopes and 
physiological parameters such as blood pressure (BP) measurements, 24 hour ECG 
and peak expiratory flow rate recordings. The specialist receiving these data can offer 
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diagnostic input and management advice without the need for the patient to travel.  
Provision of specific, relevant clinical information to the specialist are interpreted in 
the context of the clinical presentation.   
2. Real-time interactive Services: This involves remote but real time contact using IT 
tools such as telephone or video calling (eg: Skype) to enable remote consultation.   It 
follows that this modality depends on availability of relevant technology to the 
specialists and patients as well as possession of relevant IT skills by both parties.  
This has been applied in dermatology, psychology, psychiatry and nursing, as well as 
in the follow-up of chronic conditions such as diabetes, asthma and heart disease with 
an option for face-to-face (FTF) consultation if deemed necessary.  This method is 
clearly not suitable for conditions that require a detailed physical examination. 
Remote monitoring or telemetry may also be an useful tool for patients with chronic 
conditions such as in diabetes mellitus, asthma and cardiac failure following an initial FTF 
clinical assessment by a specialist. Monitoring is done on the basis on specific physiological 
variables or point of care tests, symptomatic responses and quality of life scores.  This 
modality relies on availability of equipment for home use (eg: BP monitor, home glucometer, 
electronic peak flow device) and patients ability to perform the relevant tests unsupervised at 
home and following instructions.  Hence, successful implementation requires patient 
cooperation, acquisition of skills and suitable mental and physical well-being to cooperate 
and perform the relevant task/s and generate data 
(http://www.peninsulacommunityhealth.co.uk/our-services/telehealth.htm,accessed 
04/08/2015).  Increasingly patient monitoring devices are able to acquire and transmit data in 
real time wirelessly with reduced need for patient intervention.  
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Potential benefits of telemedicine 
From the patients perspective, telemedicine enables access to health services without having 
to travel to the specialist.  It is therefore particularly relevant to patients in remote areas with 
poor access to health care or to those who are unable to travel due to transport or mobility 
problems, other disabilities, financial restrains or work commitments.  From a health service 
provider view point, using telemedicine to deal with some of the cases referred to a specialist 
should reduce the cost of assessing and monitoring a wide range of conditions and reduce the 
number of cancelled and wasted appointments. Telemedicine can also be applied to health 
education for patients and health care professionals. 
Applications of Telemedicine 
Several studies have investigated the possible role of telemedicine in clinical practice.  Whilst 
preliminary data are promising, the quality of evidence available thus far is limited as it 
mainly comes from observational studies with relatively small sample sizes. There is paucity 
of information relating to cost-effectiveness and a lack of sound research methodology with 
only a small number of adequately powered randomised control trials (RCTs). 
Surveys carried out amongst general practitioners (GPs) have suggested willingness to 
consider alternatives to conventional FTF consultations if support for IT and guidance on 
medico-legal advice is  accessible(1).  One study reported that GPs use email to communicate 
with patients and that this occurs in an unregulated and unstructured manner which is not 
compatible with the high standards set out by clinical governance frameworks in the UK 
NHS(2) and elsewhere in Europe, USA, Australia and New Zealand.  
In a survey of 713 patients in 5 primary care practices in Missouri, Columbia, USA, 78% 
were internet users, although 36.7% of respondents could not afford to pay for an internet 
connection (3).  Lack of IT skills and access to computers were the main barriers amongst 
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non-users.  Predictably, perhaps younger age, higher education, higher income, better health 
or absence of chronic illness were associated with internet use(3). This is an obvious barrier 
to reaching those patients who would benefit most from internet-based telemedicine services, 
and means that the role of older technology (the telephone [landline or mobile]) will remain 
important. A Cochrane systematic review showed that telephone consultations used in 
primary care significantly reduced the number of contact visits and ‘out of hours’ calls for 
GPs(4).  In a North American study carried out in 35,423 patients with hypertension, diabetes 
or both, use of a secure communication between patients and their physicians for clinical 
management-related enquiries was associated with improved Health Care Effectiveness Data 
and Information Set (HCEDIS) measures(5). In a randomised trial carried out in the UK of 
joint tele-consultations (virtual outreach) versus standard outpatient appointments for patients 
referred by their GP for specialist opinion, more patients in the former group were offered 
follow up appointments. This was particularly so for the Ear Nose and Throat department and 
Orthopaedics as opposed to other specialties(6).  Patient satisfaction was greater in the 
telemedicine group(6), however the cost incurred to the NHS for the telemedicine group was 
greater, although it saved time and money for the patients(7).   
The financial aspects incurred in running a telemedicine service may have reduced 
significantly in the last 10 years with the rapid proliferation of the IT industry, resulting in a 
greater proportion of the global population using smart phones and portable computers.  
Furthermore, most hospitals in the UK NHS are moving towards digital technology and 
paperless systems and these would reduce the capital costs for the establishment of 
telemedicine services.  In summary, preliminary evidence on the use of telemedicine in 
primary care seems promising giving an impetus for carrying out well designed large RCTs.  
Teleradiology has also shown some encouraging results.   Introduction of teleradiology in in 
the island of Ameland, off the coast of The Netherlands resulted in a reduced number of 
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missed fractures and a reduction in unnecessary referrals(8).  Similarly, teleradiology guided 
thrombolysis for acute stroke achieved comparable results to ‘on-site’ treatment decisions.  A 
high degree of correlation was also seen with respect to decisions on coronary angiograms 
made by transmission of digital images to smart phones via Face Time application compared 
to conventional on site reporting in the laboratory(9, 10).   
Legget et al reported high diagnostic accuracy (97%) for rheumatological conditions using 
real time televisual consultation with 58% of patients expressing a preference for  
telemedicine consultation(11).    Similar studies support use of telemedicine in long term 
management of diabetes(12-14). 
Teledermatology has been particularly successful, perhaps because diagnosis is often arrived 
on the basis of visual examination of skin lesions with less emphasis on extended history-
taking or detailed physical examination. Studies examining teledermatology have employed 
Store-and-Forward as well as real time interactive clinical services using audio-visual 
conferencing(15-20) and reported high diagnostic accuracy, good clinical outcomes, patient 
satisfaction and preference for telemedicine. 
Employing telemedicine in intensive care units (ICU) in the USA has been driven by need 
rather than by choice.  In 2010, there was a mismatch of 5,500 American board-certified 
intensivists for 6,000 ICUs in the USA(21).  Tele-ICU has an off-site command centre in 
which a critical care team comprising an intensivist and critical care nurse are linked 
remotely to the patient with real time audio, video and transmission of clinical data to offer 
support to less skilled bed side staff regarding management decisions.  Preliminary evidence 
suggests there is reduction in length of ICU stay and mortality, but further  studies are 
required to confirm the value of such a service in critically ill patients(21, 22).  There is also 
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emerging evidence favouring use of tele-cardiology in long term clinical management of 
paediatric and adult patients with heart failure and arrhythmias (23-25). 
In contrast, studies investigating the use of telemonitoring in chronic obstructive pulmonary 
disease (COPD) and asthma did not show favourable results. Telemonitoring failed to 
achieve any reduction in rates of COPD exacerbations(26).  In asthma, telemedicine has 
mainly focussed on monitoring treatment plans and electronic monitoring devices (EMDs) to 
promote compliance.  A systematic review and meta-analysis of 6 studies involving 
telephone, email or monitoring (from 813 articles) did not support the role for telemedicine 
interventions to improve asthma outcomes, although they could not exclude other 
benefits(27).  The authors concluded that further studies are needed to assess the role for 
EMDs in clinical outcomes, cost effectiveness and patient selection in management of 
chronic asthma(28). This observation that telemedicine does not inevitably improve outcomes 
reinforces the need for systematic trials in each proposed clinical application.  
Potential barriers for use of telemedicine 
The use of telemedicine in clinical practice depends on multiple factors, some of which are 
specific to patients and health care professionals.  Provision of appropriate resources 
including technical support and training for the relevant IT tools would be key for the service 
provider and the patient.  Staff delivering telemedicine services must be trained to ensure 
compliance with Caldicott principles and the Data Protection Act of 1998.  Importantly, 
development of an appropriate governance framework surrounding use of telemedicine is 
essential for medico-legal purposes, data protection and patient confidentiality.  Specific 
purpose-built tools and governance systems will be necessary.  There may also be barriers 
erected locally by organisations and staff who resist or oppose the introduction of 
telemedicine since it threatens to bring changes to working practices.  There may also be 
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issues with adequate internet connectivity in rural or isolated areas where patients benefit the 
most from telemedicine.  These concerns highlight the need for well-designed RCTs and 
cost-effectiveness studies. 
Is there a role for telemedicine in adult allergy practice in the UK NHS ? 
The organisation of the UK NHS adult allergy services differs both from allergy services in 
other countries and also from other specialties in the UK.    It is delivered by allergists, 
clinical immunologists, respiratory physicians, dermatologists, Ear Nose and Throat (ENT) 
surgeons, dermatologists, gastroenterologists and GPs with a special interest.    Also, there 
are variations with respect to professional training, availability of resources and infrastructure 
of clinical services and geographical distribution of clinics. The unmet need for allergy 
services in the UK has been highlighted in several publications including those under the 
auspices of The Royal College of Physicians and House of Lords, Science and Technology 
Committee reports(29, 30).  Given the restructuring of specialist services within the UK NHS 
in recent years, campaigns for equity of health care for all, budget cuts and high expectations 
of patients, there is a real need to be innovative in creating new service frameworks for 
delivery of allergy services.  
Allergy diagnosis depends largely on information derived from a comprehensive clinical 
history and scrutiny of records relating to previous admissions or other clinical events 
involving suspected allergic episodes (e.g. emergency department or anaesthetic records).  
The experience of the authors in a large UK regional allergy service is that in vivo diagnostic 
tests are required only in a small proportion of adults patients referred to the allergy clinic.  In 
other words, a significant proportion of referrals relate to adult patients whose symptoms are 
not in keeping with an IgE-mediated condition or where clinical history supports a 
spontaneous (idiopathic) aetiology such as chronic urticaria. Further scenarios where allergy 
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testing is often unnecessary include food intolerance, adverse reactions to some drugs, aspirin 
or non-steroidal anti-inflammatory drug (NSAID) intolerance or a spontaneous or drug-
induced anaphylaxis where the diagnosis can be arrived at through a careful clinical history.  
This highlights a potential role for telemedicine in triaging the patient following receipt of a 
referral and enabling selection of patients who require further investigations including skin 
tests and challenges in the clinic.   
There have been significant advances in in vitro diagnostics including molecular allergology 
in the last decade and a case could be made for applying telemedicine alongside  in vitro 
diagnostic tests in specific clinical scenarios (eg: allergic rhinitis, hay fever, nut allergy, oral 
allergy syndrome, seafood allergy). This approach could enable remote diagnosis and 
implementation of management plans.  A combination of a purpose built package of Store-
and-Forward and real time interactive services could be applied in such cases using tools such 
as email, telephone consultation and video calls or conferencing. Patient education (eg: 
adrenaline auto-injector training) can also be delivered using online materials or applications 
downloaded to smart phones or other portable devices.    
In the following sections we propose some models of care using telemedicine, which can be 
applied to specific clinical scenarios in UK adult allergy practice. These may be a means to 
optimise efficient use of the limited resources and meet patient satisfaction without 
compromising quality of care. Investigations and management would also remain consistent 
with British Society for Allergy and Clinical Immunology (BSACI) (31, 32) and National 
Institute of Health Care and Excellence (NICE) guidelines 
(http://guidance.nice.org.uk/CG134). This approach is based on a triaging system, so that 
only selected cases (which we estimate would be a relatively small proportion) will require a 
further FTF consultation in clinic. This would reduce overhead expenses, travel time and 
expenditure for patients and for the most part management plans could be implemented in 
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liaison with primary care.  Patients could be counselled remotely and provided with 
educational materials, either in hard copy or via a validated web tool and make it a paperless 
exercise.   This approach would require prior agreement of referral criteria and pathways with 
relevant stake holders. 
Essential pre-requisites of a telemedicine service are summarised in Table-1. Importantly, the 
bench mark for IT systems should be predefined and standardised amongst the telemedicine 
vendors to maintain equity.  Furthermore, the clinical scenarios in which telemedicine will be 
applied should be agreed with local authorities.  Standard operating protocols should be 
developed and these should be subjected to regular audits and patient satisfaction surveys.  
This service should be piloted initially and clinic schedules should be based on availability of 
space, IT support and personnel availability.   
The following proposed models of care need validation in well-designed prospective studies: 
1. Model 1: Triaging system for allergic rhinitis and hay fever referrals:  A structured 
questionnaire is made available online or in hard copy, which enables GPs to select 
patients for referral to an allergy specialist for allergen-specific immunotherapy. 
Alternatively, a combined approach of telephone consultation and a Store-and-
Forward systems may be employed by the specialist to triage patients for allergen-
specific immunotherapy (Figure-1).   
2. Model 2: Triaging for suspected cases of anaphylaxis discharged from accident and 
emergency departments and remote training (Figure-2):   
We (33) and others (34, 35) have shown that a significant proportion (50-70%) of adult 
anaphylaxis presenting to emergency units is triggered by drugs (antibiotics, NSAIDs) or 
is spontaneous (idiopathic) in aetiology and neither scenario requires allergy testing.  
Management plans usually involve counselling of patients, checking baseline serum 
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tryptase, discussing avoidance measures (where relevant) and provision of training in the 
use of self-injectable adrenaline pens.  A recent survey of 100 NHS Allergy clinics 
showed that only 52% offered annual re-training in the use of self-injectable adrenaline 
pens, with some citing lack adequate resources and a high demand for the service(36).  In 
a significant proportion of patients competence and skill in the use of adrenaline pen is 
lacking, underlining the need for periodic re-training(37-40).  Furthermore, the need to 
train healthcare professionals involved in the management of anaphylaxis has also been 
highlighted previously(40). Telemedicine tools may offer a solution through remote 
training for patients and healthcare professionals.  Real time interactive telemedicine 
services such as video-conferencing could be employed and educational materials made 
available through online videos, or applications can be downloaded onto smart phones or 
other portable devices.  Certain food allergies could also be managed using a similar 
approach using molecular allergy tests via primary care to confirm the diagnosis (eg: 
peanut allergy or wheat-dependent exercise-induced anaphylaxis).  Patients requiring skin 
tests for specific foods, drugs or challenge testing, those warranting venom 
immunotherapy and those with complex clinical presentations such as somatisation 
disorder or vocal cord dysfunction (VCD) could be invited for a FTF consultation.  
3. Model 3: Triaging for suspected food allergy:  A triaging system is also likely to 
work in this clinical scenario since the need for  skin tests or in vitro diagnostics or 
both is based on clinical presentation.  Hence, a clinical history could be obtained by a 
real-time interactive approach and cases triaged for further investigations including 
skin tests and challenges.  Patients would be counselled regarding non-allergic 
conditions such as food intolerance, and those with suspected type-1 hypersensitivity 
could undergo in vitro diagnostics via primary care. If food allergy is confirmed, the 
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patient is counselled further regarding avoidance measures and provision of training 
regarding adrenaline auto-injector as discussed under model 2. 
 
4. Model 4: Remote management of chronic urticaria (Figure-3): Telemedicine has 
been shown to be successful and real-time interactive services could be applied in 
patients with chronic urticaria with a view to confirming diagnosis and providing 
educational materials. Advice and guidelines to the GP for optimisation of therapy 
with high dose antihistamines and leukotriene antagonists could be delivered in paper 
format or via online links. Patients who require immunomodulatory therapies such as 
omalizumab or cyclosporine would be invited for a FTF consultation.  
One of the challenges with this telemedicine approach is to develop a robust and validated 
method of obtaining a structured clinical history by either an interview using telephone or 
video call, or an electronic questionnaire to be completed either by the patient or their GP.  
These have to be condition-specific and provide the necessary data set for triaging and 
making clinical decisions as discussed above.   
The development of a standard set of questions firstly involves review of questions currently 
used to obtain clinical histories across clinics and clinicians for different conditions or a given 
clinical scenario.  A comprehensive and inclusive question set could then be drawn up and 
used in consultations alongside diagnostic tests (where relevant).  Reliability could be 
demonstrated by different clinicians arriving at the same diagnosis for a patient based on the 
analysis of answers to the clinical history question set (and diagnostic tests where relevant).  
Reliability over time could also be demonstrated if the diagnosis for a patient is the same at 
two different time points (provided there is no clinical change in the patient).   This 
standardised question set should then be used in telemedicine consultations and in FTF 
consultations to check that diagnosis made using the two different modes are correlated.   
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This approach may not work for all patients since an open consultation with an opportunity to 
clarify and discuss symptoms may be warranted in some with relatively complex 
symptomatology or in those with psychosomatic or somatisation disorder. 
There are a number of measures that would be useful to use in an assessment of the 
feasibility, acceptability and usefulness of a telemedicine allergy service.   Some measures, 
such as quality of life, might already be available and would need to be assessed for the 
validity of their use in a telemedicine context.  Others, such as patient satisfaction with an 
allergy telemedicine service, would need to be developed.  Development of this type of 
patient relevant outcome measure (PROM) should also follow standard guidelines (where 
available), which would involve interviews with patients to discuss their views on such a 
service, analysis of interview data to develop a set of patient satisfaction questions which 
would then be given to a large number of patients using the service.  Similarly, the views of 
clinicians on their experiences and confidence when using telemedicine for allergy should 
also be collected and evaluated. 
Any study which aims to assess the feasibility of telemedicine for allergy would also need to 
develop a governance framework for delivery of the proposed models of care.  An important 
consideration is the security of any data or photographs that might be sent via electronic 
means.  The means of transport and storage of the data should be secure, the duration of data 
storage and access permissions would need to be decided.  Confidentiality of patient data is 
paramount in any system set up to provide telemedicine consultations.  The confidentiality of 
the consultation itself should be addressed, and patients may not have considered the issues 
involved in advance.  The patient may talk to their consultant via a telephone or computer 
from their home while others are present, such as children, other family members or friends.  
Although it should be the patients choice as to who is present during a consultation, they 
should be made aware that issues might come up during a consultation that they do not want 
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others to hear.  It is also wise for the clinician to be aware of who else is present, since this 
may influence the answers given to questions. These factors are naturally apparent in FTF 
consultations, but require extra care and consideration in telemedicine. When considering a 
governance framework for telemedicine (Table-2) for allergy, ways in which the safety of the 
system in terms of security and confidentiality can be clearly communicated to the patient 
should be developed in order to provide the patient with a level of confidence in such a 
service.   
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Conclusion 
Telemedicine presents an attractive option for the adult allergy service. Well-designed 
prospective studies are needed to evaluate its role in specific clinical conditions. These should 
take into account health economics, impact on health-related quality of life and patient and 
clinician satisfaction, to aid policy makers in making informed decisions on whether to adopt 
this approach.  Keys to the success of this approach include delineation of appropriate clinical 
contexts, patient selection, training, IT support and robust information governance 
framework.  
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Table-1: Pre-requisites of a telemedicine service and research 
Patient related factors 
1. Suitable patient – capable and willingness to  accepting of phone or online 
consultation and possession of IT skills 
2. Access to telephone, personal computer with high-speed internet access 
Service Provider 
1. Staff training and protected time 
2. Quiet room with telephone, personal computer with facilities for video calls and high 
speed internet 
3. Clear governance procedures in place 
4. Secure network to protect patient confidentiality 
5. IT support 
6. For Store-and-Forward service: good IT facilities for transmission of large files (e.g. 
high resolution images) in an encrypted format 
 
Qualitative Assurance 
 
1. Validated structured interview or questionnaire 
2. Validated patient educational tools 
3. ‘Fit for purpose’ audit tools 
4. Pre-agreed referral pathways with contingency plans for FTF consultations where 
needed 
5. Tools for measuring clinical outcome 
6. Tools for measuring cost-effectiveness 
7. Tools for measuring patient satisfaction  
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Table-2: Governance issues relating to remote communication with patients  
1. Informed consent should be sought from the patient prior to using any remote 
messaging or consultation according to local policies. 
2. Minimum required patient identifiable material should be used during 
communication 
3. Patients should be made aware of:  
o potential confidentiality and security breaches during information 
transit 
o potential messaging errors and modifications due to IT-related issues 
o potential interception of information by friends, family members or 
members of public who may have access to patients email account or 
mobile phone 
o Service disruptions of mobile phone, internet or email servers may 
potentially affect clinical management 
 
Issues relating to SMS messaging and email patient communication 
 
4. Patients should be advised to delete the messages from phones or email servers 
when they are no longer required 
5. All such communication should be included in the patients clinical record 
 
Issues relating to telephone and video-call consultations 
 
6. The patient should have an option to have a FTF consultation in addition to or 
instead of the remote consultation 
7. The patient should be advised of their right to privacy and how to maintain this 
in a remote consultation 
8. All verbal discussions and instructions should be recorded in written form (as in 
FTF consultation) 
 
 Referral for allergic rhinitis 
or hay fever  
Referring physician to forward reports: 
Serum total IgE  
SSIgE : grass pollen, birch pollen, HDM, 
fungal spores & animals (where relevant) as 
per pre-agreed protocol 
Telemedicine consultation (telephone or video call): 
 History 
 Evaluate treatment response 
 Nasal spray technique & compliance 
 Co-morbidities 
 Current treatment 
 Environment, pets, occupation 
 Discuss blood tests results & counsel 
Allergic or non-allergic rhinitis 
 Counsel 
 Demonstrate nasal 
spray technique# 
 Optimise therapy 
Follow up in few 
weeks/months to assess 
response 
Good response -
discharge 
Consider need for  
ENT review 
Allergic rhinitis/hay 
fever – deemed 
suitable for 
allergen-specific 
immunotherapy 
Allergic rhinitis or hay fever 
Potential candidate for allergen-specific 
immunotherapy 
Review in clinic for FTF consult 
(SPT, component tests, spirometry, 
counselling) 
Figure-1: An algorithm applying 
telemedicine as a triage tool in the 
referral pathway for allergic rhinitis 
and hay fever from primary care 
#demonstration for 
video call  
consultations only.  
For telephone 
consults, nasal spray 
technique education 
via written 
information or email 
or a web tool is 
employed 
  Suspected case of anaphylaxis – 
management in Emergency 
Department (ED), including acute 
tryptase measurements 
Discharged with  
 interim advice 
 prescription for adrenaline auto-
injector (AAI) &  antihistamine, 
counselling + written information 
 training ±  online or mobile 
downloaded instructions for  use of 
AAI 
 blood test form for baseline serum 
tryptase 
 provision of trainer AAI pen 
Referred to an allergy specialist 
Review of scanned ED clinical 
records, acute serum tryptase and 
baseline serum tryptase 
Telemedicine consultation on telephone or video call 
Comprehensive clinical history, 
initial diagnosis and counselling 
Further investigations not required (eg: 
spontaneous, NSAIDs, antibiotics, ACEI-induced 
angioedema, exercise-induced anaphylaxis 
Investigations required  (food or  insect sting allergy, 
FDEIA, suspected mast cell disorders, anaphylaxis 
mimcs, e.g. carcinoid)
 Avoidance advice 
where relevant 
 Food-activity diary 
where relevant 
 Discussion and 
demonstration of self-
management plan with 
trainer AAI pen (video 
call  or training video) 
 Option to review in 
clinic if needed 
 
 Interim advice 
 Discussion and demonstration of 
self-management plan with 
trainer AAI pen via video call or 
online / downloaded tools  
 Arrange clinic appointment 
Any concern – FTF consult 
appointment in clinic 
Figure-2: An algorithm applying telemedicine as a triage tool in the long term management of anaphylaxis  
 REFERRAL FOR CHRONIC URTICARIA 
Review of digital images of 
lesions/swellings 
Telemedicine (TM) consultation 
(telephone consultation or video 
call) 
 Confirm diagnosis 
 Counsel 
 Forward patient 
information sheet 
 Write to GP with 
treatment plan and 
request blood tests 
 Review blood tests 
 Follow up TM 
appointment to 
assess progress in 
few weeks 
 Diagnosis uncertain 
 Other clinical concerns 
(urticarial vasculitis, 
eczema, or other) 
 Possible allergy, needs 
tests 
 Arrange FTF review  
and/or 
 Consider further referral e.g. 
dermatology for biopsy 
 Difficult chronic urticaria 
 Patient not satisfied 
 Clinical concern 
Figure-3: An algorithm applying 
telemedicine as a triage tool in the 
referral pathway for chronic 
urticaria from primary care to an 
allergy specialist 
Good response - 
discharge from 
care 
